1.
The uptake of presymptomatic genetic testing for hereditary breast and/or ovarian cancer syndrome. Onkologija [Internet]. 2021 Nov. 30 [cited 2026 Sep. 26];25(2):16-23. Available from: https://revijaonkologija.si/Onkologija/article/view/476